InvestorsHub Logo

RLSJ84

07/27/16 8:23 PM

#218389 RE: Couch #218388

Questions are.....

Does the FDA require a new BE study with fatty meal and sprinkling?

If so how quickly can elite accomplish this BE and include a packaged "response" presentation or data to the FDA.

Does this fall into class 1 because of the additional data that would supplement original data.

Hence why I have stated even with another BE this could be done with an approval by years end.

pte

07/27/16 8:44 PM

#218393 RE: Couch #218388

Great posts on CRLs. I'll bet Eugene is more than familiar with these. My guess is he has a game plan in the works as we speak. Worst case if he can't make it happen he knows someone who can.

Drugdoctor

07/27/16 8:50 PM

#218398 RE: Couch #218388

Nice DD there Couch... A lot of questions I had about the process were answered...

Gman24

07/27/16 9:15 PM

#218403 RE: Couch #218388

Camargo huh..!!!... Nice DD Couch as always. Down but not out..!!!